BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Original Article
Year : 2026  |  Volume : 17  |  Issue : 2  |  Page : 8444-8447 Full Version
In vitro characterization of human olfactory ensheathing cells
Int J Biol Med Res. 2026; 17(2): 8444-8447  |  DOI: 10.65048/ijbmr.2026.17.2.8444.1021
Kavita Marita, G
Professor, Department of Physiology, GSL Medical College &General Hospital, NH-16, Rajamahendravaram – 533269, East Godavari District, Andhra Pradesh, India.
Correspondence Address :
Dr.G.KAVITA MARITA,
Professor, Department of Physiology,
GSL Medical College &General Hospital,
NH-16, Rajamahendravaram – 533269, East Godavari District,
Andhra Pradesh, India. E-mail: gkmarita@gmail.com
Received: January 10, 2026 Accepted: February 27, 2026 Published: April 5, 2026

Abstract
ABSTRACT: Introduction and Aim: With the promising results of transplanted OECs in regeneration of various animal models of injured spinal cord, OECs have emerged as prime candidates for cell-mediated treatment of Spinal Cord Injury (SCI). This study aimed to isolate human Olfactory Ensheathing Cells (hOECs) by enzymatic dissociation of olfactory mucosal tissue and characterize their glial cell properties.
Materials and Methods: Primary cultures of hOECs are grown on poly-L-lysine coated coverslips in multi wells supplemented with DMEM/F10, antibiotics and growth factors at 370C and 5% CO2. On the 14 day in vitro the second passage of the primary cultures of hOECs are fixed in 4% paraformaldehyde and labelled with primary antibodies for GFAP (Glial Fibrillary Acidic Protein), S-100 and p75NTR (p75 neurotrophin receptor) and with Alexa 488 secondary antibodies. The coverslips are mounted on glass slides with DAPI mounting medium visualized under fluorescence microscope. Results: Intense diffused immunofluorescence is observed with S-100, while it is punctate with P75NTR. GFAP displayed faint immunofluorescence. Intense diffuse staining with S-100 mark the Schawn cells like glial cells while punctate staining of the p75 neurotrophin receptor or p75NTR might indicate its key role cell modulation of extracellular matrix regulation. Positive immunofluorescence with GFAP, a cytoskeletal protein may suggest its role to promote cellular plasticity, in this study towards Schwann-like cellular plasticity needed for nerve regeneration.
Conclusion: In an attempt to establish peripheral nerve regeneration in Phase-I clinical trials on spinal cord injured patients we established the primary cell cultures of hOECs to study their functional properties in vitro and to derive optimal dose for transplantation.
Keywords
hOECs, GFAP, S-100, p75NTR

Introduction

Olfactory ensheathing cells (OECs) are first described by Golgi in the late 1800s [1]. They are restricted to the primary olfactory system and are thought to be a unique class of glial cells. In the human olfactory system Olfactory ensheathing cells (hOECs) mimic the functional properties of central glial cells the astrocytes and peripheral Schwann cells which stimulate and guide nerve regeneration hence it is conceivable that they might encourage nerve regeneration after injuryif applied to other parts of the central nervous system.

            One of the complexities of understanding the biology of olfactory glial cells has been the variable methods used to purify them.In the adult olfactory mucosa, the OECs represent only a small proportion of the total cell population including epithelial cells and fibroblasts. Two types of cells are identified in the olfactory mucosa of newborn rats in enzymatically dissociated tissue. They displayed features of Schwann cells and astrocytes glial cells [2]. A 50:50 mix of OECs and fibroblasts transplantation in animal models of nerve injury have suggested their role in nerve regeneration [3].

            With the growing evidence ofthe potential benefits of OECs for spinal cord and nerve root repair, to extract optimum dose of OECs for transplantation,various methods like 1) the direct harvest and use of unprocessed olfactory mucosa containing OECs2) culture of OECs  for autologous transplant and 3) the culture of OECs from cadaveric specimens of olfactory mucosa have been evaluate by various researchers [4-7]. Accordingly, the present study aimed to isolate human OECs (hOECs) by enzymatic separation protocol and to establish hOECs primary cultures for future transplant studies after obtaining approval from Institutional Ethics Committee following Helsinki declaration.

Materials and Method

1). Sample collection:

            The 4 mm size 3 tissue nasal biopsiesobtained via nasal cavity of a healthy volunteer are collected and suspended in DMEM/F12 media, supplemented with 100IU/ml Penicillin,100 IU/ml Streptomycin,50IU/ml Gentamycin, 2.5ug/ml Amphotericin B (Sigma). The tissue is cut to 0.05mm2 pieces with the help of surgical bladeand washed several times in Hank’s Balanced Salt Solution (HBSS, Gibco,USA) to separate blood clots and lamina propria. The sample is processed for histological examination and enzymatic separation of OECs with Dispase-II (Fig.1).

Fig:1.Biopsy specimen of olfactory mucosa (A-B). (1A)4mm bits of olfactory mucosal biopsy. (1B)Specimen cut to 1mm pieces under sterile conditions.

2). Histology of Olfactory mucosa:

            One of the 4mm tissue bits of olfactory mucosa is fixed with standard 10% formalin and the paraffin embedded 4 µm sections are cut and stained with standard Hematoxylin&Eosin (H&E) to identify the distribution of olfactory ensheathing cells in the tissue under 40x magnification.

Fig:2. Enzymatic digestion (A-C). (2A)Tissue fragments at the initial placing in Dispase II solution. (2B)Cell pellet after centrifugation. (2C)Olfactory ensheathing cells plated in T25 flask.

3). Isolation and primary cultures of hOECs:

            The minced nasal biopsy tissue fragments are digested with 1ml Dispase II (1mg/ml) solution and incubated for 10 min at room temperature. The enzymatic activity is stopped by adding equal volume of DMEM/F12 media containing FBS. The cells aregently triturated and washed with HBSS. The dissociated cells are pelleted and plated on poly-L-Lysine coated petridishes containing with 1ml DMEM/F12 media, 10%FBS,1% Insulin/Transferin/Selenium supplement (Gibco), 100 IU/ml Penicilin,100 IU/ml Streptomycin,50 IU/ml Gentamycin,2.5ug/ml Amphotericin B,10ng/ml basic Fibroblastic Growth Factor (bFGF, Sigma-Aldrich) and 10ng/ml Epidermal Growth Factor (EGF, Sigma-Aldrich).The cells reached confluency by 7 DIV. For the second passage the cells are seeded at the density of 2x105 cells/cm2in T25 flask (Nunc). These cultures are maintained for 14 days in at 370C and 5%CO2.The culture medium is replaced every 3 days. The hOECsare harvested after 14 DIV.

Fig: 3.Haemocytometer: The glass counting chamber consists of 5 large squares (each 1mm), four corner squares and one centre square and loading the haemocytometer with cells.

4). Cell concentration calculation:

In order to obtain total number of cellsin the cell suspension cells present in four corner squares are counted.

Total number of cells/ml = C x V x D x 104, where D is the dilution factor, C is the average cell count in four corner squares and V is the volume of cell suspension.

% viability = Viable cells/ total cellcountx 100

5). Confirmation of hOEC’s by Immunocytofluoresence:

            The isolated hOECS cultured on coated coverslips in 4 well multiplates (Nunc) of passage 2 are fixed with 4% paraformaldehyde for 20 min at 4oC. Fixed cells are permeabilized with 0.5% Triton X-100 in PBS for 15 min and blocked with 1% BSA at room temperature for 30 min. Following fixation, the cells are incubated with primary antibodies p75NTR, S-100, GFAP in 1:100 (Santa Cruz Biotechnology, Inc. Europe) at 4°C overnight and followed with PBS wash 3x. The cells are incubated with secondary antibody tagged withAlexa 488 for 1 hr at 37°C. The coverslips are mounted on glass slides usingmounting medium containing DAPI (Sigma-Aldrich) and fluorescence images are recorded by Leica TCS SPE laser scanning confocal microscope (Leica Microsystem, Germany) at 60X magnification.

Results

1). Histology of Olfactory mucosa:

4µm sections of olfactory mucosal sections stained with H&E are observed under 40x magnification (Fig.4).

Fig:4. 10% Formalin fixedparaffin embed sections of human olfactory mucosal biopsy stained with standard H&E stain viewed under light microscope at 40x magnification.

2). Enzymatic isolation and primary culture of OECs:

            The cells obtained from enzymatic digestion with Dispase -II are plated in poly-L-lysine coated T25 culture flask and started proliferating from 4 DIV. Bipolar cells with flattened morphology became confluent within 21 days, yielding 2x103 cells/mg from each tissue fragment.

Fig. 5. Phase contrast microphotographs of primary cultures of hOECs at 1 DIV, 4 DIV, 7 DIV AND 14 DIV. By 4 DIV the cells shown large flattened cell body with tapering processes. At 7 DIV the hOECs formed network with well-defined flat fibroblast like elongated cell body with extended processes. At 14 DIV Confluent cellular network of hOECs is observed.  Magnification is at 40X.

3). Cell viability:

In trypan blue dye exclusion assay approximately 98% of the cells were viable without dye inclusion and 2% of the cells take up the dye. The cells with a clear cytoplasm are scored as viable cells, while stained ones as non-viable cells (Fig. 6).

Fig.6.Viability analysis of hOECs.Light microscopic representation of one of the four corners of haemocytometer containing viable hOECs stained with trypan blue.

4). Immunoflorescence staining of hOECS:

            On the 14 dayin vitro the second passage of the primary cultures of hOECS are fixed in 4% paraformaldehyde and labelled with primary antibodies for S-100 and p75NTR (p75 NeurotrophinRreceptor) GFAP (Glial Fibrillary Acidic Protein) and with Alexa 488 secondary antibodies. The coverslips are mounted on glass slides with nuclear stain DAPI mounting medium visualized under confocal fluorescence microscope. Intense punctate immunofluorescence is observed with S-100 on the cell bodies and at the origin of processes.  P75NTR displayed punctate immunostaining on the processes near the cell bodes. Diffused immunofluorescence is observed around the nucleus for GFAP (Fig.7)

Fig. 7. Confocal photomicrographs of green immunofluorescence staining of OECs with S-100, p75NTR and GFAP. Nucleus is stained with DAPI (blue).  Magnification at 60X.

Discussion

Olfactory ensheathing cells (OECs) constitute a unique population of glia that accompany and ensheath the primary olfactory axons both in primitive animals and human. They are thought to exhibit trophic action for growth of olfactory axons within the developing and adult olfactory nervous system. When cultured OECs transplanted in experimental electrolytic lesion induced paraplegia in rats exhibited growth of damaged axons, repair of spinal cord and improved motor functions [8,9]. Recently OECs have emerged as potential candidates for cell-mediated repair by promoting remyelination of damaged axons by exhibiting characteristics of both astrocytes and Schwann cells in rat models of spinal cord injury[10-15]. 

            To extract the optimum dose of OECs for transplantation, various methods like harvesting OECs from unprocessed olfactory mucosa, culture of OECs from biopsies of olfactory mucosa for autologous transplant and cadaveric specimens have been discussed earlier. In an attempt to establish the hOECs primary cultures for future clinical transplant studies the present study isolated hOECs by enzymatic separation protocol and maintained primary cultures till 14 DIV.  Expression of glial and Schwann cell biomarkers on 14 DIV, the hOECshave shown a discrete pattern of immunostaining for S100, p75NTR and GFAP.   

            Schwann cells are specialized support cells found in the peripheral nervous system, wrap around nerve fibres, forming an insulating layer called myelin.  As these cells proliferate and migrate to the injury site to support axonal regrowth, an increase in progenitor Schwann cell markers may indicate active repair and regenerative process. S-100 protein, a calcium-binding protein, is found abundantly in the cytoplasm of mature Schwann cells. Zimmerman et.al., 1995[16] reported increased expression of S-100 in glia and muscle cells during differentiation suggesting that they play a vital role in proliferation, differentiation, protein phosphorylation and cell survival of OECs [17]. p75NTR (p75 neurotrophin receptor) is involved in functioning of various ligands and may facilitate or inhibit axonal growth or promote cell survival or deathis determined by its quantity of expression [18].GFAP is a widely accepted marker for the intermediate filaments of central glia, the astrocytes,is another reliable marker for OECs in zebrafish as well as guppy and goldfish [19]. 

Conclusions

The most important striking difference between the olfactory nervous system and other CNS tissues is that the olfactory epithelium, projection neurons and olfactory bulb interneurons are continuously generated throughout life. With the promising results oftransplanted OECs in regeneration studies of various animal models of injured spinal cord, OECs have emerged as prime candidates for cell-mediated treatment of Spinal Cord Injury (SCI). As the current study has focused on establishing hOECs primary cultures and preliminary immunocytochemical characterisation of OECs, further study on isolation of hOECs for the optimal dose for transplantation under cGMP conditions for Phase -1 clinical trials is warranted.

References

[1] Golgi, 1875Golgi C. Sulla finaanatomia del bulbi olfactorii. Ti Rivista Sperimentale di Freniatria. 1875;1:403–425.

[2] Pixley S.K. The olfactory nerve contains two populations of glia, identified both in vitro and in vivo. Glia. 1992;5:269–284.

[3] Barnett S.C., Alexander C.A., Gilson J., Clark L., Dunn L., Papanastassiou V., Kennedy P.G.E., Ishwashita Y., Franklin R.J.M. Identification of the human olfactory ensheathing cell (OEC) and demonstration of its ability to remyelinate experimentally-induced demyelinating lesions in the rat spinal cord. Brain. 2000;123:1581–1588.

[4] Rubio M.P., Munoz-Quiles C., Ramón-Cueto A. Adult olfactory bulbs from the primate provides reliable ensheathing glia for cell transplantation. Glia. 2008;56:539–551. 

[5] Techangamsuwan S., Imbschweiler I., Kreutzer R., Kreutzer M., Baumgärtner W., Wewetzer K. Similar behaviour and primate-like properties of adult canine Schwann cells and olfactory ensheathing cells in long-term culture. Brain Res. 2008;1240:31–38.

[6] Techangamsuwan S., Haas L., Rohn K., Baumgärtner W., Wewetzer K. Distinct cell tropism of canine distemper virus strains to adult olfactory ensheathing cells and Schwann cells in vitro. Virus Res. 2009;144:195–201. 

[7] Lim F., Martín-Bermejo M.J., García-Escudero V., Gallego-Hernández M.T., García-Gómez A., Rábano A., Díaz-Nido J., Avila J., Moreno-Flores M.T. Reversibly immortalized human olfactory ensheathing glia from an elderly donor maintain neuroregenerative capacity. Glia. 2010;58:546–558.

[8] Ramón-Cueto A., Nieto-Sampedro M. Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Exp. Neurol. 1994;127:232–244.

[9] Rubio M.P., Munoz-Quiles C., Ramón-Cueto A. Adult olfactory bulbs from the primate provides reliable ensheathing glia for cell transplantation. Glia. 2008;56:539–551. 

[10] Raisman G. Olfactory ensheathing cells: Another miracle cure for spinal cord injury. Nat Rev Neurosci. 2001;2:369–375. 

[11] Wewetzer K, Verdù E, Angelov DN, et al. Olfactory ensheathing glia and Schwann cells: two of a kind? Cell Tissue Res. 2002;309:337–345. 

[12] Barnett SC, Riddell JS. Olfactory ensheathing cells (OECs) and the treatment of CNS injury: Advantages and possible caveats. J Anat. 2004;204:57–67. 

[13] Mackay-Sim A. Olfactory ensheathing cells and spinal cord repair. Keio J Med. 2005;54:8–14. 

[14] Granger N, Blamires H, Franklin RJM, et al. Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational model. Brain. 2012;135:3227–3237. 

[15] Coutts DJC, Humphries CE, Zhao C, et al. Embryonic-derived olfactory ensheathing cells remyelinate focal areas of spinal cord demyelinationmore efficiently than neonatal or adult-derived cells. Cell Transplant. 2013;22:1249–1261.

[16] Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull. 1995;37(4):417-29. 

[17] Smithson LJ, Kawaja MD. A comparative examination of biomarkers for olfactory ensheathing cells in cats and guinea pigs. Brain Res. 2009 Aug 11;1284:41-53.

[18] Cragnolini AB, Friedman WJ. The function of p75NTR in glia. Trends Neurosci. 2008 Feb;31(2):99-104. 

[19] Lazzari G, Colleoni S, Galli C. Derivation of neural precursors from bovine preimplantation embryos. Methods Mol Biol. 2013;1074:199-207. 


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications